BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
DNA fingerprint
,
Trichostatin A
,
rs2300478
,
PDX1
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Forkhead Box Protein L2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ovary
Endometrium
Pituitary gland
Cervix
Myometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis…
FOXL2: a gene central to ovarian function.
FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Early gonadal differentiation is associated with the antagonistic action of Foxl2 and Dmrt1l in the …
The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pembrolizumab in Treating Patients With Malignant Mesothelioma
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ